Chengdu Mingyang Pharmaceutical Co.,Ltd

Company Description

Chengdu Mingyang Pharmaceutical Co.,Ltd. was founded in September 2008.
Its parent company, Chengdu Yuan Dong Pharmaceutical Co.,Ltd. located in Chengdu, is one of new high-tech enterprises specializing in production, sales and R&D of APIs and intermediates.It is also the first enterprise in southChengdu Mingyang Pharmaceutical Co.,Ltdst China passing the New Edition of GMP.The company?s main production base is located in No.1,Tongzhan Road, Qingbaijiang District, Chengdu, it covers an area of 40 Mu with 16000 square meters of building area.The company mainly produce APIs and intermediates, such as Bisoprolol fumarate, Nalmefene hydrochloride, Ubenimex, Fasudil hydrochloride, Olanzapine, Clopidogrel hydrogen sulfate, Ibandronate sodium, Sodium fusidate, Naloxone hydrochloride , Nebivolol Hydrochloride, Ubenimex, Fasudil Hydrochloride, Olanzapine, Clopidogrel Hydrogen Sulfate, Sodium Ibandronate, Fusidic Acid Sodium, Naloxone Hydrochloride as Up to now 9 API products have already obtained the registered documents of approval and GMP certificates.  The Products not only meet the requirement of domestic market, but also have bee exported to many developed countries and districts including the United States, Britain, France, etc. and have been enjoying good reputation.